20,000 dram banknote of 2024 issue put into circulation in Armenia

YEREVAN, January 27. /ARKA/. The Central Bank of Armenia reported about putting into circulation from January 27 this year a banknote with a nominal value of 20,000 drams of 2024 issue, which is a legal tender on the territory of the country and is subject to unconditional acceptance at its nominal value without time limitations.
On the reverse of the 2024 banknote a visible color protective element has been added: the figure expressing the nominal value in the lower left corner is printed with optically changing ink.
On the obverse of the banknote the year of issue has been changed to 2024, as well as the signature of the Armenian Minister of Finance.
The banknotes of 20,000 drams nominal value issued in 1999-2021 remain in circulation without restrictions and without changes in circulation conditions.

spot_img

POPULAR

Armenian dram strengthens against US dollar and weakens against euro and ruble

YEREVAN, August 21. /ARKA/. The average market exchange rate of the US dollar to the Armenian dram on the Armenian foreign exchange market on August 21, 2026, fell by 0.1 point to 365.16 drams compared to August 20.

Armbanks Weekly Digest: Key Events in the Armenian Financial Market (August 17–23)

Key developments in Armenia's financial market this week included new banking compliance requirements, measures against account fraud, and decisions related to capital market development.

US dollar, euro, and ruble up against  Armenian dram

YEREVAN, August 20. /ARKA/. The average market exchange rate for the US dollar to the Armenian dram on the Armenian foreign exchange market as of August 20, 2026, increased by 0.3 points to 365.26 drams compared to August 19.

S&P affirms Armenia’s ratings, maintaining a positive outlook

The international rating agency S&P Global Ratings affirmed the long- and short-term sovereign ratings of the Republic of Armenia at 'BB-/B', maintaining a positive outlook, the Ministry of Finance reported.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img